Jiping Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jiping Liao has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Guangfa Wang
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China
11 shared publications Cheng Zhang
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, China
5 shared publications- Chunbo Zhang
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China
3 shared publications Kunyao Yu
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, China
3 shared publicationsWen Sun
Department of Respiratory and Critical Care Medicine, Peking University First Hospital
3 shared publications- Yijue Zhong
Jiangsu Provincial Key Laboratory of Geriatrics, Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
3 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2590197
Bronchoscopic management of airway fistulas: a clinical analysis of 45 cases with integrated bioinformatic analysis
Airway fistula represents a complex clinical condition where the optimal bronchoscopic management remains controversial. This study aims to evaluate clinical characteristics, bronchoscopic treatment efficacy, and prognostic factors. This retrospective study analysed 45 patients with fistulas who underwent a total of 56 bronchoscopic intervention sessions over the past seven years. The fistulas were categorized and analysed based on their size, clinical features and treatment efficacy, with prognostic factors for healing being evaluated. In parallel, a bioinformatic analysis was initiated with 2075 genes sourced from GeneCards. Following filtration, the top 20 hub genes were identified and subsequently subjected to pathway enrichment analysis to elucidate the underlying mechanisms. Compared to the non-remission group, the remission group exhibited significantly smaller fistula diameters, higher lymphocyte counts, and lower high-sensitivity C-reactive protein (hsCRP) levels. Prognostic analysis revealed that fistula size and hsCRP level were independent predictors. Small fistulas (≤5 mm) cases solely underwent blocking agent intervention had a significantly higher remission rate. While the others (>5 mm) were mostly managed with stents, endobronchial valves, and cardiac occluders. Bioinformatic analysis of public data identified significant enrichment in the PI3K-AKT signaling pathway and cytokine-cytokine receptor interaction pathway, pinpointing six core genes, including CXCL8, IL1B, IL6, TNF, TGFB1, and IL13. Prioritize bronchoscopic treatment with inflammation control for small fistulas; recommend combined therapies for large fistulas.The PI3K-AKT and cytokine pathways may be involved in healing and represent potential targets for future drug development.
- 24 November 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2590197
Open AccessBronchoscopic management of airway fistulas: a clinical analysis of 45 cases with integrated bioinformatic analysis
Airway fistula represents a complex clinical condition where the optimal bronchoscopic management remains controversial. This study aims to evaluate clinical characteristics, bronchoscopic treatment efficacy, and prognostic factors. This retrospective study analysed 45 patients with fistulas who underwent a total of 56 bronchoscopic intervention sessions over the past seven years. The fistulas were categorized and analysed based on their size, clinical features and treatment efficacy, with prognostic factors for healing being evaluated. In parallel, a bioinformatic analysis was initiated with 2075 genes sourced from GeneCards. Following filtration, the top 20 hub genes were identified and subsequently subjected to pathway enrichment analysis to elucidate the underlying mechanisms. Compared to the non-remission group, the remission group exhibited significantly smaller fistula diameters, higher lymphocyte counts, and lower high-sensitivity C-reactive protein (hsCRP) levels. Prognostic analysis revealed that fistula size and hsCRP level were independent predictors. Small fistulas (≤5 mm) cases solely underwent blocking agent intervention had a significantly higher remission rate. While the others (>5 mm) were mostly managed with stents, endobronchial valves, and cardiac occluders. Bioinformatic analysis of public data identified significant enrichment in the PI3K-AKT signaling pathway and cytokine-cytokine receptor interaction pathway, pinpointing six core genes, including CXCL8, IL1B, IL6, TNF, TGFB1, and IL13. Prioritize bronchoscopic treatment with inflammation control for small fistulas; recommend combined therapies for large fistulas.The PI3K-AKT and cytokine pathways may be involved in healing and represent potential targets for future drug development.
- Open Access
- 8 October 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1650014
The value of cough sound monitoring via an audio-enabled smartwatch for OSA screening in COPD patients: a cross-sectional exploratory study
Objective: The purpose of this study is to explore the value of cough sounds and forced exhalation sounds monitored by smartwatches with audio collection capabilities for screening obstructive sleep apnea (OSA) in patients with chronic obstructive pulmonary disease (COPD).Methods: Stable COPD patients were recruited from an outpatient clinic. All participants completed questionnaires and underwent pulmonary function testing and overnight polysomnography (PSG). A novel smartwatch capable of collecting audio signals was worn to continuously monitor peripheral oxygen saturation (SpO₂), heart rate (HR), heart rate variability (HRV), and respiratory rate (RR). Additionally, voluntary cough and forced exhalation sounds were recorded twice daily. Audio data were denoised, segmented, and analyzed using time- and frequency-domain features. Correlations between audio features and OSA diagnosis/severity were assessed and a predicting model were developed based on these data.Results: Among the 29 participants with stable COPD, 26 underwent PSG, and 17 were diagnosed with comorbid OSA. Multiple cough and forced exhalation subfeatures correlated significantly with OSA diagnosis and apnea and hypopnea index (AHI). Cough sounds showed the highest correlation with OSA diagnosis (r = −0.6629, p < 0.001). A logistic regression model using a cough sound subfeature (the median of MFCC_35) achieved 92% accuracy with a Cohen’s kappa value of 0.8276 in predicting OSA in COPD patients.Conclusion: This study demonstrates a strong association between cough sounds and OSA risk in COPD patients. Cough sounds recorded by smartwatches may serve as a valuable tool for screening OSA in COPD patients, contributing to the management of patients with overlap syndrome.
- 8 October 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1650014
Open AccessThe value of cough sound monitoring via an audio-enabled smartwatch for OSA screening in COPD patients: a cross-sectional exploratory study
Objective: The purpose of this study is to explore the value of cough sounds and forced exhalation sounds monitored by smartwatches with audio collection capabilities for screening obstructive sleep apnea (OSA) in patients with chronic obstructive pulmonary disease (COPD).Methods: Stable COPD patients were recruited from an outpatient clinic. All participants completed questionnaires and underwent pulmonary function testing and overnight polysomnography (PSG). A novel smartwatch capable of collecting audio signals was worn to continuously monitor peripheral oxygen saturation (SpO₂), heart rate (HR), heart rate variability (HRV), and respiratory rate (RR). Additionally, voluntary cough and forced exhalation sounds were recorded twice daily. Audio data were denoised, segmented, and analyzed using time- and frequency-domain features. Correlations between audio features and OSA diagnosis/severity were assessed and a predicting model were developed based on these data.Results: Among the 29 participants with stable COPD, 26 underwent PSG, and 17 were diagnosed with comorbid OSA. Multiple cough and forced exhalation subfeatures correlated significantly with OSA diagnosis and apnea and hypopnea index (AHI). Cough sounds showed the highest correlation with OSA diagnosis (r = −0.6629, p < 0.001). A logistic regression model using a cough sound subfeature (the median of MFCC_35) achieved 92% accuracy with a Cohen’s kappa value of 0.8276 in predicting OSA in COPD patients.Conclusion: This study demonstrates a strong association between cough sounds and OSA risk in COPD patients. Cough sounds recorded by smartwatches may serve as a valuable tool for screening OSA in COPD patients, contributing to the management of patients with overlap syndrome.
Forty-five-year-old man with small nodular and ground-glass opacities on CT
His oxygen saturation was 86% on room air (altitude, 3650 m). The laboratory results were normal except those for polycythaemia (haemoglobin, 209 g/L) and hyperglobulinaemia (immunoglobulin G, 20.71 g/L), the antinuclear antibody (ANA) was 1:100, and lymphocytes and calcium levels were normal. Spirometry results were within normal limits with forced expiratory volume in one second (FEV1) of 82%, forced vital capacity (FVC) of 84%, total lung capacity (TLC) of 80% and diffusion capacity of the lung for carbon monoxide (DLCO) of 93% predicted values.
Forty-five-year-old man with small nodular and ground-glass opacities on CT
His oxygen saturation was 86% on room air (altitude, 3650 m). The laboratory results were normal except those for polycythaemia (haemoglobin, 209 g/L) and hyperglobulinaemia (immunoglobulin G, 20.71 g/L), the antinuclear antibody (ANA) was 1:100, and lymphocytes and calcium levels were normal. Spirometry results were within normal limits with forced expiratory volume in one second (FEV1) of 82%, forced vital capacity (FVC) of 84%, total lung capacity (TLC) of 80% and diffusion capacity of the lung for carbon monoxide (DLCO) of 93% predicted values.
- Open Access
- 1 February 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Intelligent wearable devices with audio collection capabilities to assess chronic obstructive pulmonary disease severity
Background: Intelligent wearable devices have potential for chronic obstructive pulmonary disease (COPD) monitoring, but the effectiveness of combining cough and blowing sounds for disease assessment is unclear. Objective: The objective was to assess COPD severity via physiological parameters and audio data collected by a smartwatch. Methods: COPD patients underwent lung function tests, electrocardiograms, blood gas analysis, and 6-min walk tests. The patients’ peripheral arterial oxygen saturation (SpO 2 ), heart rate variability (HRV), heart rate (HR), and respiratory rate (RR) were continuously monitored via a smartwatch for 7–14 days, and voluntary cough and forceful blowing sounds were recorded twice daily. The HR, SpO 2 , and RR were categorized into all-day, sleep, and wake periods and summarized using the mean, standard deviation, median, 25th percentile, 75th percentile and percent variation. The correlations among lung function, physiological parameters, and audio data were analyzed to develop a model for predicting COPD severity. Results: Twenty-nine stable patients, with a mean age of 67.0 ± 5.8 years, were enrolled, and 89.7% were male. HR, HRV, RR, cough sounds, and blowing sounds were significantly correlated with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade, with cough sounds showing the highest correlation (r = 0.7617, p < .001). Cough sounds also had the strongest correlation with the mean 6-minute walking distance (r = 0.6847, p < .001), whereas blowing sounds had the strongest correlation with the Body mass index, airflow Obstruction, Dyspnea, and Exercise capacity index (r = −0.6749, p < .001). A logistic regression model using the RR and blowing sounds as key predictors achieved accuracies of 0.77–0.89 in determining the GOLD grade, with a Cohen's kappa coefficient of 0.6757. Conclusions: Audio data were more strongly correlated with lung function in COPD patients than were physiological parameters. A smartwatch with audio collection capabilities effectively assessed COPD severity. Trial Registration: ClinicalTrials.gov NCT05551169
- 1 February 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Open AccessIntelligent wearable devices with audio collection capabilities to assess chronic obstructive pulmonary disease severity
Background: Intelligent wearable devices have potential for chronic obstructive pulmonary disease (COPD) monitoring, but the effectiveness of combining cough and blowing sounds for disease assessment is unclear. Objective: The objective was to assess COPD severity via physiological parameters and audio data collected by a smartwatch. Methods: COPD patients underwent lung function tests, electrocardiograms, blood gas analysis, and 6-min walk tests. The patients’ peripheral arterial oxygen saturation (SpO 2 ), heart rate variability (HRV), heart rate (HR), and respiratory rate (RR) were continuously monitored via a smartwatch for 7–14 days, and voluntary cough and forceful blowing sounds were recorded twice daily. The HR, SpO 2 , and RR were categorized into all-day, sleep, and wake periods and summarized using the mean, standard deviation, median, 25th percentile, 75th percentile and percent variation. The correlations among lung function, physiological parameters, and audio data were analyzed to develop a model for predicting COPD severity. Results: Twenty-nine stable patients, with a mean age of 67.0 ± 5.8 years, were enrolled, and 89.7% were male. HR, HRV, RR, cough sounds, and blowing sounds were significantly correlated with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade, with cough sounds showing the highest correlation (r = 0.7617, p < .001). Cough sounds also had the strongest correlation with the mean 6-minute walking distance (r = 0.6847, p < .001), whereas blowing sounds had the strongest correlation with the Body mass index, airflow Obstruction, Dyspnea, and Exercise capacity index (r = −0.6749, p < .001). A logistic regression model using the RR and blowing sounds as key predictors achieved accuracies of 0.77–0.89 in determining the GOLD grade, with a Cohen's kappa coefficient of 0.6757. Conclusions: Audio data were more strongly correlated with lung function in COPD patients than were physiological parameters. A smartwatch with audio collection capabilities effectively assessed COPD severity. Trial Registration: ClinicalTrials.gov NCT05551169
- 2 January 2024
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 136 (1) , 30-35
Correlation of morning dry mouth with clinical features of OSA in a community population: a cross-sectional study
- 2 January 2024
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 136 (1) , 30-35
Correlation of morning dry mouth with clinical features of OSA in a community population: a cross-sectional study
- Open Access
- 1 January 2024
- Published by SAGE Publications in Digital Health
- Vol. 10
COVID-19 surveillance based on consumer wearable devices
Background: Consumer wearable devices such as wristbands and smartwatches have potential application value in communicable disease surveillance. Objective: We investigated the ability of wearable devices to monitor COVID-19 patients of varying severity. Methods: COVID-19 patients with mobile phones supporting wearable device applications were selected from Dalian Sixth People Hospital. Physiological parameters from the wearable devices and electronic questionnaires were collected from the device wearing until 14 days post-discharge. Clinical information during hospitalization was also recorded. Based on imaging data, the patients were categorized into the milder group without pneumonia and the more severe group with pneumonia. We plotted the curves of the physiological parameters of the two groups to compare the differences and changes. Results: Ninety-eight patients were included in the analysis. The mean age was 39.6 ± 10.5 years, including 45 males (45.9%). There were 24 asymptomatic patients, 10 mild patients, 60 moderate patients, and 4 severe patients. Compared with the milder group, the more severe group had higher heart rate-related parameters, while the heart rate variability (HRV) was the opposite. In the more severe group, the heart rate-related parameters showed a downward trend from 0 to 7 days after the fever resolution. Among them, the resting heart rate and sleep heart rate decreased on the 25th day after the onset and were close to the milder group 1 week after discharge. Conclusions: Consumer wearable devices have the potential to monitor respiratory infections. Heart rate-related parameters obtained from these devices can be sensitive indicators of COVID-19 severity and correlate with disease evolution. Trial registration: ClinicalTrials.gov NCT04459637.
- 1 January 2024
- Published by SAGE Publications in Digital Health
- Vol. 10
Open AccessCOVID-19 surveillance based on consumer wearable devices
Background: Consumer wearable devices such as wristbands and smartwatches have potential application value in communicable disease surveillance. Objective: We investigated the ability of wearable devices to monitor COVID-19 patients of varying severity. Methods: COVID-19 patients with mobile phones supporting wearable device applications were selected from Dalian Sixth People Hospital. Physiological parameters from the wearable devices and electronic questionnaires were collected from the device wearing until 14 days post-discharge. Clinical information during hospitalization was also recorded. Based on imaging data, the patients were categorized into the milder group without pneumonia and the more severe group with pneumonia. We plotted the curves of the physiological parameters of the two groups to compare the differences and changes. Results: Ninety-eight patients were included in the analysis. The mean age was 39.6 ± 10.5 years, including 45 males (45.9%). There were 24 asymptomatic patients, 10 mild patients, 60 moderate patients, and 4 severe patients. Compared with the milder group, the more severe group had higher heart rate-related parameters, while the heart rate variability (HRV) was the opposite. In the more severe group, the heart rate-related parameters showed a downward trend from 0 to 7 days after the fever resolution. Among them, the resting heart rate and sleep heart rate decreased on the 25th day after the onset and were close to the milder group 1 week after discharge. Conclusions: Consumer wearable devices have the potential to monitor respiratory infections. Heart rate-related parameters obtained from these devices can be sensitive indicators of COVID-19 severity and correlate with disease evolution. Trial registration: ClinicalTrials.gov NCT04459637.
- 18 December 2023
- Vol. 55 (6) , 1074-1081
2013—2020年北京市慢性阻塞性肺疾病急性加重女性住院患者的流行病学和住院费用分析
研究北京市慢性阻塞性肺疾病急性加重(acute exacerbation of chronic obstructive pulmonary disease, AECOPD)女性住院患者的流行病学特征及住院费用。 选择2013—2020年北京市AECOPD女性患者的住院医保数据进行回顾性分析, 记录其年龄分布、合并症情况、住院时间、住院费用以及流行病学特征(时间和空间分布特点)。 纳入166家医院57 911例住院患者, 平均年龄(78.84±8.59)岁, 80~89岁患者(49.06%)最多, 70~79岁(31.08%)次之, 18~50岁(0.41%)最少。合并冠心病、高血压以及心力衰竭的患者占比分别为30.60%、30.52%和26.54%。每日住院人次的中位数为18(IQR: 16), 且2013—2020年8年中总体呈增长趋势, 2015年开始明显增加, 上升趋势持续至2019年, 2020年则有所回落。冬春季住院人次占比(54.09%)高于夏秋季(45.91%)。各市辖区总住院人次占比排在前三位的分别为西城区(14.18%)、朝阳区(14.12%)和丰台区(13.47%); 城市西部、中心城区和东北部住院人次密度较高, 而近郊区住院人次密度则相对较低。AECOPD女性患者的住院时间和住院费用中位数分别为12 d和20 648.37元。城区患者的住院时间和住院费用均高于郊区, 差异有统计学意义(P<0.001)。西药费用是住院总费用的主要部分(33.32%)。研究时段住院费用总体呈先增长后降低随之趋于稳定的变化特征, 不同合并症患者的住院费用差异明显。 北京市AECOPD女性住院患者以70岁及以上老年患者为主, 常合并心血管疾病, 主要在冬春季节发病且有地域差异, 其住院费用与患者年龄、合并症以及所在地区密切相关。
- 18 December 2023
- Vol. 55 (6) , 1074-1081
2013—2020年北京市慢性阻塞性肺疾病急性加重女性住院患者的流行病学和住院费用分析
研究北京市慢性阻塞性肺疾病急性加重(acute exacerbation of chronic obstructive pulmonary disease, AECOPD)女性住院患者的流行病学特征及住院费用。 选择2013—2020年北京市AECOPD女性患者的住院医保数据进行回顾性分析, 记录其年龄分布、合并症情况、住院时间、住院费用以及流行病学特征(时间和空间分布特点)。 纳入166家医院57 911例住院患者, 平均年龄(78.84±8.59)岁, 80~89岁患者(49.06%)最多, 70~79岁(31.08%)次之, 18~50岁(0.41%)最少。合并冠心病、高血压以及心力衰竭的患者占比分别为30.60%、30.52%和26.54%。每日住院人次的中位数为18(IQR: 16), 且2013—2020年8年中总体呈增长趋势, 2015年开始明显增加, 上升趋势持续至2019年, 2020年则有所回落。冬春季住院人次占比(54.09%)高于夏秋季(45.91%)。各市辖区总住院人次占比排在前三位的分别为西城区(14.18%)、朝阳区(14.12%)和丰台区(13.47%); 城市西部、中心城区和东北部住院人次密度较高, 而近郊区住院人次密度则相对较低。AECOPD女性患者的住院时间和住院费用中位数分别为12 d和20 648.37元。城区患者的住院时间和住院费用均高于郊区, 差异有统计学意义(P<0.001)。西药费用是住院总费用的主要部分(33.32%)。研究时段住院费用总体呈先增长后降低随之趋于稳定的变化特征, 不同合并症患者的住院费用差异明显。 北京市AECOPD女性住院患者以70岁及以上老年患者为主, 常合并心血管疾病, 主要在冬春季节发病且有地域差异, 其住院费用与患者年龄、合并症以及所在地区密切相关。
- Open Access
- 4 June 2021
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-6
A severe case of human coronavirus 229E pneumonia in an elderly man with diabetes mellitus: a case report
Background: With pandemic of coronavirus disease 2019 (COVID-19), human coronaviruses (HCoVs) have recently attached worldwide attention as essential pathogens in respiratory infection. HCoV-229E has been described as a rare cause of lower respiratory infection in immunocompetent adults. Case presentation: We reported a 72-year-old man infected by HCoV-229E with rapid progression to acute respiratory distress syndrome, in conjunction with new onset atrial fibrillation, intensive care unit acquired weakness, and recurrent hospital acquired pneumonia. Clinical and radiological data were continuously collected. The absolute number of peripheral T cells and the level of complement components diminished initially and recovered after 2 months. The patient was successfully treated under intensive support care and discharged from the hospital after 3 months and followed. Conclusion: HCoV-229E might an essential causative agent of pulmonary inflammation and extensive lung damage. Supportive treatment was essential to HCoVs infection on account of a long duration of immunological recovery in critical HCoV-229E infection.
- 4 June 2021
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-6
Open AccessA severe case of human coronavirus 229E pneumonia in an elderly man with diabetes mellitus: a case report
Background: With pandemic of coronavirus disease 2019 (COVID-19), human coronaviruses (HCoVs) have recently attached worldwide attention as essential pathogens in respiratory infection. HCoV-229E has been described as a rare cause of lower respiratory infection in immunocompetent adults. Case presentation: We reported a 72-year-old man infected by HCoV-229E with rapid progression to acute respiratory distress syndrome, in conjunction with new onset atrial fibrillation, intensive care unit acquired weakness, and recurrent hospital acquired pneumonia. Clinical and radiological data were continuously collected. The absolute number of peripheral T cells and the level of complement components diminished initially and recovered after 2 months. The patient was successfully treated under intensive support care and discharged from the hospital after 3 months and followed. Conclusion: HCoV-229E might an essential causative agent of pulmonary inflammation and extensive lung damage. Supportive treatment was essential to HCoVs infection on account of a long duration of immunological recovery in critical HCoV-229E infection.
- Open Access
- 1 June 2021
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 215, 112127
Identification of exosome miRNAs in bronchial epithelial cells after PM2.5 chronic exposure
- 1 June 2021
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 215, 112127
Open AccessIdentification of exosome miRNAs in bronchial epithelial cells after PM2.5 chronic exposure
- Open Access
- 1 January 2020
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 11 (19) , 5758-5767
PM2.5 downregulates MicroRNA-139-5p and induces EMT in Bronchiolar Epithelium Cells by targeting Notch1
PM2.5 was closely linked to lung cancer worldwide. However, the mechanism involved in PM2.5 induced lung cancer is still largely unknown. In this study, we performed chronic PM2.5 stimulation animal and cells model to investigate the carcinogenetic mechanisms of PM2.5 by targeting EMT through Notch1 signal pathway. Next, we focused on the miRNA involved in PM2.5 induced Notch1 pathway activation. We found chronic PM2.5 could induce EMT event in vivo and in vitro, while reducing miR-139-5p expression and activating Notch1 pathway meanwhile. And blocking Notch1 signal pathway by specific small molecule inhibitor could reverse PM2.5 induced EMT. Then, overexpression of miR-139-5p downregulated the expression of Notch1 protein in untreated 16HBE cells. Importantly, overexpression of miR-139-5p blocked Notch1 pathway activation and inhibited EMT event in PM2.5 treated cells. These results indicate that PM2.5 induces EMT event through Notch1 signal pathway and miR-139-5p is a novel regulator of PM2.5-induced EMT by targeting Notch1. Our conclusion is that overexpression of miR-139-5p can down-regulate the expression of Notch1 and reverse the occurrence of malignant lung events induced by chronic exposure to PM2.5.
- 1 January 2020
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 11 (19) , 5758-5767
Open AccessPM2.5 downregulates MicroRNA-139-5p and induces EMT in Bronchiolar Epithelium Cells by targeting Notch1
PM2.5 was closely linked to lung cancer worldwide. However, the mechanism involved in PM2.5 induced lung cancer is still largely unknown. In this study, we performed chronic PM2.5 stimulation animal and cells model to investigate the carcinogenetic mechanisms of PM2.5 by targeting EMT through Notch1 signal pathway. Next, we focused on the miRNA involved in PM2.5 induced Notch1 pathway activation. We found chronic PM2.5 could induce EMT event in vivo and in vitro, while reducing miR-139-5p expression and activating Notch1 pathway meanwhile. And blocking Notch1 signal pathway by specific small molecule inhibitor could reverse PM2.5 induced EMT. Then, overexpression of miR-139-5p downregulated the expression of Notch1 protein in untreated 16HBE cells. Importantly, overexpression of miR-139-5p blocked Notch1 pathway activation and inhibited EMT event in PM2.5 treated cells. These results indicate that PM2.5 induces EMT event through Notch1 signal pathway and miR-139-5p is a novel regulator of PM2.5-induced EMT by targeting Notch1. Our conclusion is that overexpression of miR-139-5p can down-regulate the expression of Notch1 and reverse the occurrence of malignant lung events induced by chronic exposure to PM2.5.